1.
HIV-1 group P infection: towards a dead-end infection?
by Alessandri-Gradt, Elodie
AIDS (London), 2018-06-19, Vol.32 (10), p.1317-1322
2.
Level of double negative T cells, which produce TGF-β and IL-10, predicts CD8 T-cell activation in primary HIV-1 infection
by PETITJEAN, Gaël
AIDS (London), 2012, Vol.26 (2), p.139-148
3.
HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment
by Singh, Kasha P
AIDS (London), 2017-09-24, Vol.31 (15), p.2035-2052
4.
Control of Human Viral Infections by Natural Killer Cells
by Jost, Stephanie
Annual review of immunology, 2013-03-21, Vol.31 (1), p.163-194
5.
Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women
by McKinnon, Lyle R
Nature medicine, 2018-05, Vol.24 (4), p.491-496
6.
Intimate partner violence and engagement in HIV care and treatment among women: a systematic review and meta-analysis
by Hatcher, Abigail M
AIDS (London), 2015-10-23, Vol.29 (16), p.2183-2194
7.
Microglial activation is inversely associated with cognition in individuals living with HIV on effective antiretroviral therapy
by Rubin, Leah H
AIDS (London), 2018-07-31, Vol.32 (12), p.1661-1667
8.
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, rand...
by Richel, Olivier, Dr
The lancet oncology, 2013, Vol.14 (4), p.346-353
9.
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
by Brown, Julia A
Nature, 2006-09-21, Vol.443 (7109), p.350-354
10.
HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls
by Kooij, Katherine W
AIDS (London), 2016, Vol.30 (2), p.241-250
11.
The gut microbiome and HIV-1 pathogenesis: a two-way street
by Dillon, Stephanie M
AIDS (London), 2016-11-28, Vol.30 (18), p.2737-2751
12.
Do people living with HIV experience greater age advancement than their HIV-negative counterparts?
by De Francesco, Davide Davide
AIDS (London), 2018-10-16, Vol.33 (2), p.259-268
13.
Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment
by HAREZLAK, Jarek
AIDS (London), 2011, Vol.25 (5), p.625-633
14.
Integrated single-cell analysis of multicellular immune dynamics during hyperacute HIV-1 infection
by Kazer, Samuel W
Nature medicine, 2020-04, Vol.26 (4), p.511-518
15.
Basic science and pathogenesis of ageing with HIV: potential mechanisms and biomarkers
by Lagathu, Claire
AIDS (London), 2017-06-01, Vol.31 Suppl 2 (Supplement 2), p.S105-S119
16.
Long-term body composition changes in antiretroviral-treated HIV-infected individuals
by Grant, Philip M
AIDS (London), 2016-11-28, Vol.30 (18), p.2805-2813
17.
Role of siglecs and related glycan-binding proteins in immune responses and immunoregulation
by Bochner, Bruce S., MD
Journal of allergy and clinical immunology, 2014, Vol.135 (3), p.598-608
18.
CD8 + T cell efficacy in vaccination and disease
by Appay, Victor
Nature medicine, 2008-06, Vol.14 (6), p.623-628
19.
Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivo
by Maldini, Colby R
Nature medicine, 2020-11, Vol.26 (11), p.1776-1787
20.
Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children
by Ananworanich, Jintanat
AIDS (London), 2014-04-24, Vol.28 (7), p.1015-1020
